Načítá se...

伊马替尼对慢性髓性白血病慢性期儿童身高的影响

OBJECTIVE: To evaluate the effect of imatinib on growth impairment in children with chronic myeloid leukemia (CML-CP) in the chronic phase. METHODS: From July 2018 to July 2019, questionnaires were distributed to CML children aged <18 years at the time of diagnosis who were receiving imatinib for...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Zhonghua Xue Ye Xue Za Zhi
Médium: Artigo
Jazyk:Inglês
Vydáno: Editorial office of Chinese Journal of Hematology 2020
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7449767/
https://ncbi.nlm.nih.gov/pubmed/32810960
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.07.003
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!